WALTHAM, Mass., Oct. 30, 2008 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report third quarter 2008 results on Wednesday, November 5, 2008. A conference call and webcast hosted by OXiGENE management will begin at 2:00 p.m. EDT (11:00 a.m. PDT).
